- Home
- ELA vs BDTX Comparison
ELA vs BDTX Comparison
Compare ELA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELA
- BDTX
- Stock Information
- Founded
- ELA 1965
- BDTX 2014
- Country
- ELA United States
- BDTX United States
- Employees
- ELA N/A
- BDTX N/A
- Industry
- ELA Consumer Specialties
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELA Consumer Discretionary
- BDTX Health Care
- Exchange
- ELA Nasdaq
- BDTX Nasdaq
- Market Cap
- ELA 156.2M
- BDTX 132.5M
- IPO Year
- ELA N/A
- BDTX 2020
- Fundamental
- Price
- ELA $6.08
- BDTX $2.61
- Analyst Decision
- ELA Strong Buy
- BDTX Strong Buy
- Analyst Count
- ELA 1
- BDTX 6
- Target Price
- ELA $9.00
- BDTX $14.83
- AVG Volume (30 Days)
- ELA 67.0K
- BDTX 1.2M
- Earning Date
- ELA 08-06-2025
- BDTX 08-05-2025
- Dividend Yield
- ELA N/A
- BDTX N/A
- EPS Growth
- ELA 15.15
- BDTX N/A
- EPS
- ELA 0.28
- BDTX 0.09
- Revenue
- ELA $188,774,278.00
- BDTX $70,000,000.00
- Revenue This Year
- ELA $7.61
- BDTX N/A
- Revenue Next Year
- ELA $6.27
- BDTX N/A
- P/E Ratio
- ELA $21.31
- BDTX $28.49
- Revenue Growth
- ELA 14.19
- BDTX N/A
- 52 Week Low
- ELA $4.20
- BDTX $1.20
- 52 Week High
- ELA $7.88
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- ELA 52.85
- BDTX 59.61
- Support Level
- ELA $5.97
- BDTX $2.43
- Resistance Level
- ELA $6.16
- BDTX $2.72
- Average True Range (ATR)
- ELA 0.26
- BDTX 0.17
- MACD
- ELA 0.04
- BDTX -0.01
- Stochastic Oscillator
- ELA 76.30
- BDTX 75.77
About ELA Envela Corporation
Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.